A Polyvalent Peptide CD40 Nanoagonist for Targeted Modulation of Dendritic Cells and Amplified Cancer Immunotherapy
Sign Up to like & getrecommendations! Published in 2022 at "Advanced Materials"
DOI: 10.1002/adma.202109432
Abstract: Targeted immunomodulation through biomolecule‐based nanostructures, especially to dendritic cells (DCs), holds great promise for effective cancer therapy. However, construction of high‐performance agonist by mimicking natural ligand to activate immune cell signaling is a great challenge… read more here.
Keywords: pva cd40; polyvalent peptide; cd40; dendritic cells ... See more keywords